BioDelivery Sciences to Report First Quarter 2019 Financial Results
26 April 2019 - 6:30AM
BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a
rapidly growing commercial stage specialty pharmaceutical company
dedicated to patients living with chronic pain, today announced
that it will report its first quarter 2019 financial results after
the close of the U.S. financial markets on Monday, May 6,
2019. The company will host a conference call at 4:30 PM
Eastern Time to discuss the results and provide an update on
business operations.
Conference Call Dial In & Webcast Information:
Date: |
Monday, May 6, 2019 |
Time: |
4:30 PM Eastern Time |
Domestic: |
877-407-0789 |
International: |
201-689-8562 |
Passcode: |
13690336 |
Webcast: |
http://public.viavid.com/index.php?id=134355 |
About BioDelivery Sciences
International, Inc.
BioDelivery Sciences International,
Inc. (NASDAQ: BDSI) is a rapidly growing commercial-stage
specialty pharmaceutical company dedicated to patients living with
chronic pain. BDSI is utilizing its novel and proprietary
BioErodible MucoAdhesive (BEMA®) technology and other drug delivery
technologies to develop and commercialize, either on its own or in
partnership with third parties, new applications of proven
therapies aimed at addressing important unmet medical needs. BDSI's
marketed products and those in development address serious and
debilitating conditions such as chronic pain, breakthrough cancer
pain, and opioid dependence. For more information, please visit us
at www.bdsi.com or follow us
on Facebook.com/BioDeliverySI or Twitter BDSI
@BioDeliverySI.
Mary Coleman 919-582-0188 mcoleman@bdsi.com
BioDelivery Sciences (NASDAQ:BDSI)
Historical Stock Chart
From Apr 2024 to May 2024
BioDelivery Sciences (NASDAQ:BDSI)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about BioDelivery Sciences International Inc (NASDAQ): 0 recent articles
More News Articles